Login

Mike Crawley, CEO of Northland Power Inc., shares insights in "The View From The C-Suite" segment. 00:10:00

Share On Facebook Share On Twitter

Mike Crawley. President/CEO, Northland Power Inc ;

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Exploring Opportunities in Life Sciences Direct Lending: Insights Live with Armen Panossian and Danielle Poli
00:10:00
GoTo Gojek Tokopedia announces changes to its board of directors and commissioners, with Patrick Walujo, the company's co-founder and head of the capital firm, involved.
00:00:00
Tissue Regenix Group "has the opportunity to become a global commercial organisation" - Danny Lee, CEO, Tissue Regenix Group
00:10:00
Paul Canvert: Driving Recruitment & Retention in Transport | Paul Sarant - CEO, MD & Executive Director of K&S Corporation Limited
00:10:00
Why Choose Legacy Financial Strategies? | Michael Lutz, CEO, Legacy Financial Strategies, LLC.
00:10:00
How AI Transforms Financial Services: Insights from Sameena Shah, JPMorgan Chase & Co. | MIT EmTech Digital Conference 2022
00:10:00
The core of enterprise security is identity|BarakKaufman,Senior Director, Product, SailPoint
00:10:00
diverse founders leveraging financial innovation|Garnet S. Heraman,Managing Partner,Aperture Venture Capital
00:10:00
Jim Russo on Trade War Impacts, Tariffs, and Altrius' Market Strategy | James M. Russo , Founder , Altrius Capital Management Inc.
00:10:00
Consultants Analyze Firm Challenges for Optimal Solutions
00:00:00
Interview with Dr. Philip Toleikis, President & CEO of Sernova Corp. - Dr. Philip Toleikis, President & CEO of Sernova Corp.
00:10:00
Yuri Maltsev on the Inherent Hostility of Communism and the Myth of Convergence

© 2017 - Neuhu+